TrialLancet (London, England)2017

Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial.

Ari J Green et al.PubMed ↗Publisher ↗

No numbers read from the abstract.